Reeves DC, Lummis SC (2002). «The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review)». Molecular Membrane Biology19 (1): 11-26. PMID11989819. doi:10.1080/09687680110110048.
Boyd GW, Low P, Dunlop JI, Ward M, Vardy AW, Lambert JJ, Peters J, Conolly CN (2002). «Assembly and cell surface expression of homomeric and heteromeric 5-HT3 receptors: The role of oligomerisation and chaperone proteins». Mol Cell Neurosci21 (1): 38-50. PMID12359150. doi:10.1006/mcne.2002.1160.
Niesler B, Walstab J, Combrink S, Moeller D, Kapeller J, Rietdorf J, Boenisch H, Goethert M, Rappold G, Bruess M (2007). «Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C, 5- HT3D and 5-HT3E». Mol Pharmacol72 (Mar 28): 8-17. PMID17392525. doi:10.1124/mol.106.032144.
Niesler, Beate (February 2011). «5-HT3 receptors: potential of individual isoforms for personalised therapy». Current Opinion in Pharmacology11 (1): 81-86. PMID21345729. doi:10.1016/j.coph.2011.01.011.
Quirk, Phillip L.; Rao, Suma; Roth, Bryan L.; Siegel, Ruth E. (15 de agosto de 2004). «Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cells». Journal of Neuroscience Research77 (4): 498-506. ISSN0360-4012. PMID15264219. doi:10.1002/jnr.20185.
Sanger GJ (September 2008). «5-hydroxytryptamine and the gastrointestinal tract: where next?». Trends in Pharmacological Sciences29 (9): 465-471. PMID19086255. doi:10.1016/j.tips.2008.06.008.
Sugita S, Shen KZ, North RA (1992). «5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala». Neuron8 (1): 199-203. PMID1346089. doi:10.1016/0896-6273(92)90121-S.
Rondé P, Nichols RA (1998). «High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum». J Neurochem70 (3): 1094-1103. PMID9489730. doi:10.1046/j.1471-4159.1998.70031094.x.
Imanishi, N.; Iwaoka, K.; Koshio, H.; Nagashima, S. Y.; Kazuta, K. I.; Ohta, M.; Sakamoto, S.; Ito, H. et al. (2003). «New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation». Bioorganic & Medicinal Chemistry11 (7): 1493-1502. PMID12628674. doi:10.1016/S0968-0896(02)00557-6.Se sugiere usar |número-autores= (ayuda)
Delagrange, Philippe; Emerit, M.Boris; Merahi, Nacera; Abraham, Christine; Morain, Philippe; Rault, Sylvain; Renard, Pierre; Pfeiffer, Bruno et al. (1996). «Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization». European Journal of Pharmacology316 (2–3): 195-203. ISSN0014-2999. PMID8982686. doi:10.1016/S0014-2999(96)00680-2.Se sugiere usar |número-autores= (ayuda)
Ashoor, A.; Nordman, J.; Veltri, D.; Susan Yang, K. -H.; Shuba, Y.; Al Kury, L.; Sadek, B.; Howarth, F. C. et al. (2013). «Menthol Inhibits 5-Ht3 Receptor-Mediated Currents». Journal of Pharmacology and Experimental Therapeutics347 (2): 398-409. PMID23965380. doi:10.1124/jpet.113.203976.Se sugiere usar |número-autores= (ayuda)
Solt, Ken; Stevens, Renna J.; Davies, Paul A.; Raines, Douglas E. (4 de agosto de 2005). «General Anesthetic-Induced Channel Gating Enhancement of 5-Hydroxytryptamine Type 3 Receptors Depends on Receptor Subunit Composition». Journal of Pharmacology and Experimental Therapeutics (American Society for Pharmacology & Experimental Therapeutics (ASPET)) 315 (2): 771-776. ISSN0022-3565. doi:10.1124/jpet.105.090621.
Delagrange, Philippe; Emerit, M.Boris; Merahi, Nacera; Abraham, Christine; Morain, Philippe; Rault, Sylvain; Renard, Pierre; Pfeiffer, Bruno et al. (1996). «Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization». European Journal of Pharmacology316 (2–3): 195-203. ISSN0014-2999. PMID8982686. doi:10.1016/S0014-2999(96)00680-2.Se sugiere usar |número-autores= (ayuda)
Solt, Ken; Stevens, Renna J.; Davies, Paul A.; Raines, Douglas E. (4 de agosto de 2005). «General Anesthetic-Induced Channel Gating Enhancement of 5-Hydroxytryptamine Type 3 Receptors Depends on Receptor Subunit Composition». Journal of Pharmacology and Experimental Therapeutics (American Society for Pharmacology & Experimental Therapeutics (ASPET)) 315 (2): 771-776. ISSN0022-3565. doi:10.1124/jpet.105.090621.
Reeves DC, Lummis SC (2002). «The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review)». Molecular Membrane Biology19 (1): 11-26. PMID11989819. doi:10.1080/09687680110110048.
Boyd GW, Low P, Dunlop JI, Ward M, Vardy AW, Lambert JJ, Peters J, Conolly CN (2002). «Assembly and cell surface expression of homomeric and heteromeric 5-HT3 receptors: The role of oligomerisation and chaperone proteins». Mol Cell Neurosci21 (1): 38-50. PMID12359150. doi:10.1006/mcne.2002.1160.
Niesler B, Walstab J, Combrink S, Moeller D, Kapeller J, Rietdorf J, Boenisch H, Goethert M, Rappold G, Bruess M (2007). «Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C, 5- HT3D and 5-HT3E». Mol Pharmacol72 (Mar 28): 8-17. PMID17392525. doi:10.1124/mol.106.032144.
Niesler, Beate (February 2011). «5-HT3 receptors: potential of individual isoforms for personalised therapy». Current Opinion in Pharmacology11 (1): 81-86. PMID21345729. doi:10.1016/j.coph.2011.01.011.
Quirk, Phillip L.; Rao, Suma; Roth, Bryan L.; Siegel, Ruth E. (15 de agosto de 2004). «Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cells». Journal of Neuroscience Research77 (4): 498-506. ISSN0360-4012. PMID15264219. doi:10.1002/jnr.20185.
Sanger GJ (September 2008). «5-hydroxytryptamine and the gastrointestinal tract: where next?». Trends in Pharmacological Sciences29 (9): 465-471. PMID19086255. doi:10.1016/j.tips.2008.06.008.
Sugita S, Shen KZ, North RA (1992). «5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala». Neuron8 (1): 199-203. PMID1346089. doi:10.1016/0896-6273(92)90121-S.
Rondé P, Nichols RA (1998). «High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum». J Neurochem70 (3): 1094-1103. PMID9489730. doi:10.1046/j.1471-4159.1998.70031094.x.
Imanishi, N.; Iwaoka, K.; Koshio, H.; Nagashima, S. Y.; Kazuta, K. I.; Ohta, M.; Sakamoto, S.; Ito, H. et al. (2003). «New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation». Bioorganic & Medicinal Chemistry11 (7): 1493-1502. PMID12628674. doi:10.1016/S0968-0896(02)00557-6.Se sugiere usar |número-autores= (ayuda)
Delagrange, Philippe; Emerit, M.Boris; Merahi, Nacera; Abraham, Christine; Morain, Philippe; Rault, Sylvain; Renard, Pierre; Pfeiffer, Bruno et al. (1996). «Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization». European Journal of Pharmacology316 (2–3): 195-203. ISSN0014-2999. PMID8982686. doi:10.1016/S0014-2999(96)00680-2.Se sugiere usar |número-autores= (ayuda)
Ashoor, A.; Nordman, J.; Veltri, D.; Susan Yang, K. -H.; Shuba, Y.; Al Kury, L.; Sadek, B.; Howarth, F. C. et al. (2013). «Menthol Inhibits 5-Ht3 Receptor-Mediated Currents». Journal of Pharmacology and Experimental Therapeutics347 (2): 398-409. PMID23965380. doi:10.1124/jpet.113.203976.Se sugiere usar |número-autores= (ayuda)